Skip to main content

Table 2 Case fatality and other characteristics of the studies of S. aureus ventilator-associated pneumonia

From: Nosocomial methicillin resistant Staphylococcus aureus pneumonia - epidemiology and trends based on data of a network of 586 German ICUs (2005-2009)

Study site, year published

Number of patients

Years of study

Mean age (years)

Male gender

(%)

Length of hospital stay (days)

Total charges, median

Crude in-hospital mortality

Infection related mortality

   

MRSA

MSSA

MRSA

MSSA

MRSA

MSSA

MRSA

MSSA

MRSA

MSSA

MRSA

MSSA

USA 2010 [33]

142

2005-2008

66

63

46%

60%

14

14

70,028$

71,186 $

29%

20%

  

Germany 2010*

2,411

2005-2009

67

60

67%

65%

    

*27%

*14%

  

France 2008 [67]

42

2004

57

#59

38%

#57%

41

#43

8,915€

#8,398€

38%

#29%

  

USA 2006 [31]

154

2002-2003

74

67

56%

53%

20

15

40,734$

36,523$

29%

36%

  

USA 2005 [21]

60

1999-2004

58.4

55.2

  

^16

^16

  

55%

56%

41%

39%

Germany 2005 [68]

1,851

1997-2002

        

*17%

*7%

  
 

134

1997-2004

68

63

71%

72%

    

59%

40%

  

France 2004 [28]

171

 

64

58

45%

62%

°30

°27

  

49%

29%

  

Spain 1998 [70]

139

1990-1994

55

43

78%

72%

    

56%

38%

  

Netherlands 1998 [28]

256

         

33%

29%

  

Spain 1995 [27]

86

1990-1995

69

57

66%

57%

      

56%

41%

Spain 1994 [25]

49

1991-1993

60

44

81%

60%

      

75%

12%

  1. Bold if statistically significant *ICU mortality, # control group i.e. matched patients not only patients with MSSA pneumonia, ^infection related length of stay, °ICU stay after VAP onset * Data from the Krankenhaus Infection Surveilance System (KISS)